LISA M MAIER, MD
Medical Practice at Jackson St, Denver, CO
License number
Colorado 34387
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Colorado 34387
Category
Osteopathic Medicine
Type
Pulmonary Disease
License number
Colorado 34387
Category
Medical Practice
Type
Occupational Medicine
Address
Address
1400 Jackson St, Denver, CO 80206
Phone
(303) 388-4461
(303) 270-2174 (Fax)
(303) 270-2174 (Fax)
Personal information
See more information about LISA M MAIER at radaris.comName
Address
Phone
2080 Grape St, Denver, CO 80207
2080 Grape St, Denver, CO 80207
2378 Birch St, Denver, CO 80207
Professional information
See more information about LISA M MAIER at trustoria.com
Dr. Lisa M Maier, Denver CO - MD (Doctor of Medicine)
Dr. Lisa M Maier, Denver CO - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
National Jewish Health
1400 Jackson St, Denver 80206
(303) 388-4461 (Phone), (303) 398-1476 (Fax)
1400 Jackson St, Denver 80206
(303) 388-4461 (Phone), (303) 398-1476 (Fax)
Certifications:
Critical Care Medicine, 1997, Internal Medicine, 1994, Occupational Medicine, 2010, Pulmonary Disease, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
National Jewish Health
1400 Jackson St, Denver 80206
National Jewish Health
1400 Jackson St, Denver 80206
1400 Jackson St, Denver 80206
National Jewish Health
1400 Jackson St, Denver 80206
Education:
Medical School
Duke University School Of Medicine
Graduated: 1991
Duke University School Of Medicine
Graduated: 1991
Lisa A Maier, Denver CO
Lisa A Maier, Denver CO
Specialties:
Pulmonologist
Address:
1400 Jackson St, Denver, CO 80206
Methods And Compositions For Beryllium-Induced Disease
Methods And Compositions For Beryllium-Induced Disease
US Patent:
2006026, Nov 23, 2006
Filed:
Mar 10, 2006
Appl. No.:
11/373581
Inventors:
Andrew Fontenot - Denver CO, US
Brian Kotzin - Westlake CA, US
Lee Newman - Denver CO, US
Lisa Maier - Denver CO, US
Brian Kotzin - Westlake CA, US
Lee Newman - Denver CO, US
Lisa Maier - Denver CO, US
International Classification:
C12Q 1/00, G01N 33/567, G01N 33/20
US Classification:
435004000, 435007200, 436080000
Abstract:
The present invention provides for methods for detection, diagnosis and prognosis of beryllium-induced disease. In one embodiment, the methods include exposing immune cells from subjects suspected of having beryllium-induced disease to beryllium and assessing the Th-1 cytokines produced. Other embodiments include the use of exposing immune cells from subjects suspected of having beryllium-induced disease to beryllium and assessing Th-1 cytokines produced and using these assessments to indicate the stage of progression of the disease. Therapeutic methods involve assessing the onset or progression of beryllium-induced disease before during and after exposure to a treatment for the disease.